NCT04659512View on ClinicalTrials.gov

Recurrent Neovascular Age-related Macular Degeneration After Therapy Suspension

CompletedOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

February 28, 2019

Study Completion Date

June 6, 2020

Conditions
Age-related Macular Degeneration
Trial Locations (1)

11282

St Eriks Eye Hospital, Stockholm

All Listed Sponsors
lead

St. Erik Eye Hospital

OTHER

NCT04659512 - Recurrent Neovascular Age-related Macular Degeneration After Therapy Suspension | Biotech Hunter | Biotech Hunter